CD47 and neoplasm: Expected beneficial effects of this immunotherapy involve the inhibition of tumor angiogenesis and invasion, decrease of tumor-induced macrophage apoptosis and functional impairment, and depletion of CD47-expressing cancer stem cells that are key contributors to tumor relapse and chemoresistance [213].